Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Perkins

Showing results (411-420 of 427) with videos related to

Pageof 43
Sort By:
Journal of Lower Genital Tract Disease|March 7, 2022
Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test ResultsMaria Demarco, Didem Egemen, Noorie Hyun, et al.
Eclinicalmedicine|June 9, 2020
A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programsMaria Demarco, Noorie Hyun, Olivia Carter-Pokras, et al.
Clinical & Translational Immunology|February 12, 2026
CD56<sup>bright</sup>NK cells are negatively associated with antibody response to vaccination in people with multiple sclerosis on B-cell-depleting therapyGriffith B Perkins, Christopher M Hope, Cheng Sheng Chai, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell LymphomaVictor Yazbeck, Danielle Shafer, Edward B Perkins, et al.
Microbiology Spectrum|October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumanniiSara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|September 29, 2025
Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Kidney International|March 19, 2022
Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19Griffith B Perkins, Matthew Tunbridge, Tania Salehi, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
BMC Infectious Diseases|December 30, 2025
Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysisSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Pageof 43

Showing results (411-420 of 427) with videos related to

Sort By:
Pageof 43
Journal of Lower Genital Tract Disease|March 7, 2022
Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test ResultsMaria Demarco, Didem Egemen, Noorie Hyun, et al.
Eclinicalmedicine|June 9, 2020
A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programsMaria Demarco, Noorie Hyun, Olivia Carter-Pokras, et al.
Clinical & Translational Immunology|February 12, 2026
CD56<sup>bright</sup>NK cells are negatively associated with antibody response to vaccination in people with multiple sclerosis on B-cell-depleting therapyGriffith B Perkins, Christopher M Hope, Cheng Sheng Chai, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell LymphomaVictor Yazbeck, Danielle Shafer, Edward B Perkins, et al.
Microbiology Spectrum|October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumanniiSara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|September 29, 2025
Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Kidney International|March 19, 2022
Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19Griffith B Perkins, Matthew Tunbridge, Tania Salehi, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
BMC Infectious Diseases|December 30, 2025
Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysisSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Pageof 43